DexCom, Inc.

This Stock Could Be the Big Winner Out of Oura’s IPO

Glucose monitoring company DexCom’s investment in Oura values the company at just over $5 billion. Oura is looking to go public at a valuation above $15 billion.

Yahoo Finance · 28/09/2026 · lire l'article ↗

Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care

MILAN, September 28, 2026--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today released its "Dexcom State of Type 2 Report: Global Access and Attitudes to Diabetes Technology" in advance of the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28-Oct. 2. The company also announced a partnership to become the official continuous glucose monitor of Team Novo Nordisk.

Yahoo Finance · 28/09/2026 · lire l'article ↗

Is DexCom (DXCM) Cheap After Its Leadership Reshuffle Or Already Fairly Priced?

DexCom (DXCM) just reshuffled its leadership team, with longtime finance chief Jereme Sylvain stepping into a combined EVP and Chief Operating Officer role that now includes responsibility for global operations and quality. Recent boardroom moves at DexCom have arrived at a time when the 90-day share price return of 27.79% and year-to-date gain of 31.85% point to building momentum. However, the 1-year total shareholder return of 29.97% contrasts with a weaker 3-year record and a deeper 5-year...

Yahoo Finance · 24/09/2026 · lire l'article ↗

DexCom (DXCM) Promotes Former CFO Jereme Sylvain To Chief Operating Officer

DexCom (NasdaqGS:DXCM) has promoted former Chief Financial Officer Jereme Sylvain to EVP and Chief Operating Officer. Healthcare executive Glenn S. Boehnlein has joined DexCom's board of directors, adding external industry experience to governance. The leadership shift, including Sylvain's promotion and Boehnlein's board appointment, deserves weighing alongside DexCom's broader fundamentals and risks. Take a look at 3 other big wins we have identified for DexCom. For readers looking to...

Yahoo Finance · 23/09/2026 · lire l'article ↗

Global Wearable Biosensors Market Trends, Strategies and Forecast to 2036 Featuring Abbott Labs, Dexcom, Medtronic, Roche, Apple, Samsung Electronics Co., Garmin and Other Key Players

Dublin, Sept. 21, 2026 (GLOBE NEWSWIRE) -- "Wearable Biosensors Market - Global Forecast to 2036" has been added to ResearchAndMarkets.com's offering.According to the research report, the global wearable biosensors market is projected to reach USD 105.5 billion by 2036 from USD 35.5 billion in 2026, growing at a CAGR of 12.5% during the forecast period (2026-2036). The growth of this market is primarily driven by the escalating demand for continuous health monitoring, the rising prevalence of ch

Yahoo Finance · 21/09/2026 · lire l'article ↗

Dexcom gives CFO Jereme Sylvain expanded role

Sylvain will work as chief operating officer of the diabetes technology company while continuing as its CFO.

Yahoo Finance · 16/09/2026 · lire l'article ↗